Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer.

ABSTRACT:

Background

The treatment for men diagnosed with localized prostate cancer has changed over time given the increased attention to the harms associated with over-diagnosis and the development of protocols for active surveillance.

Methods

We examined trends in the treatment of men diagnosed with localized prostate cancer between 2004 and 2015, using the most recently available data from Surveillance, Epidemiology, and End Results Program (SEER)-Medicare. Patients were stratified by Gleason score, age, and race groups.

Results

The use of active surveillance increased from 22% in 2004-2005 to 50% in 2014-2015 for patients with a Gleason score of 6 or below and increased from 9% in 2004-2005 to 13% in 2014-2015 for patients with a Gleason score of 7 or above. Patients with

SUBMITTER: Liu Y 

PROVIDER: S-EPMC8374746 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature